论文部分内容阅读
新适应证拉莫三嗪缓释片获批用于癫痫大发作辅助治疗葛兰素史克公司日前宣布,美国FDA已经批准其抗癫痫药物拉莫三嗪缓释片用于13岁及以上的原发性全身强直阵挛发作患者。
New indications lamotrigine extended release tablets approved for the treatment of epilepsy episodes adjuvant GlaxoSmithKline recently announced that the United States FDA has approved its anti-epileptic drug lamotrigine extended-release tablets for 13 years and older in the original Patients with generalized tonic-clonic seizures.